Cargando…
Co‐testing in cervical screening among 40‐ to 42‐year‐old women is unreasonable
INTRODUCTION: The screening program for cervical cancer in Sweden recommends the use of primary human papillomavirus (HPV) screening for women aged ≥30 to 65 years. Co‐testing with both HPV analysis and cytology is recommended at the first screening after the age of 40 years. To fulfil co‐testing, a...
Autores principales: | Borgfeldt, Christer, Leksell, Anneli, Forslund, Ola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564562/ https://www.ncbi.nlm.nih.gov/pubmed/34988970 http://dx.doi.org/10.1111/aogs.14311 |
Ejemplares similares
-
Promotion of Cervical Screening among Long-term Non-attendees by Human Papillomavirus Self-sampling
por: Ernstson, Avalon, et al.
Publicado: (2021) -
14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
por: Asciutto, Katrin Christine, et al.
Publicado: (2020) -
Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection
por: Ernstson, Avalon, et al.
Publicado: (2020) -
The art of being unreasonable: lessons in unconventional thinking
por: Broad, Eli, et al.
Publicado: (2012) -
Unreasonable Men
por: Seidler, Victor
Publicado: (2013)